Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
AUTOR(ES)
Araujo, F G
RESUMO
Doses of 200 mg of azithromycin per kg (body weight) administered by the oral route daily for 10 days completely protected mice against death caused by intraperitoneal infection with Toxoplasma gondii. The same treatment regimen also protected 80% of mice infected intracerebrally, which suggests that azithromycin attains active concentrations in the inflamed central nervous system.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172266Documentos Relacionados
- In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii.
- Trovafloxacin is active against Toxoplasma gondii.
- Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
- Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
- Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.